# clm_F838E1612E57

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 304,399,000 United States dollar  
valid_from: 2012-06-30  
valid_to: 2012-09-30  
published: 2012-07-25  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_82AF3B3F2E9E  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 304,399,000 United States dollar", as of 2012-06-30 (until 2012-09-30). Claim clm_F838E1612E57, https://asof.is/claim/clm_F838E1612E57, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q2 FY2012, filed 2012-07-25  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677412003062/0001206774-12-003062-index.htm (primary, SEC EDGAR 10-Q Q2 FY2012, published 2012-07-25)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 231,789,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_F838E1612E57](/claim/clm_F838E1612E57.md) | [clm_C5D81A308356](/claim/clm_C5D81A308356.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.